LNWTC
EW icon

Laird Norton Wetherby Trust Company’s Edwards Lifesciences EW Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Sell
22,586
-617
-3% -$51.7K 0.04% 336
2026
Q1 		$1.86M Buy
23,203
+1,183
+5% +$97.5K 0.04% 330
2025
Q4 		$1.88M Buy
+22,020
New +$1.81M 0.04% 334
2022
Q2 		– Sell
-3,531
Closed -$415K – 145
2022
Q1 		$415K Sell
3,531
-99
-3% -$11.1K 0.04% 119
2021
Q4 		$470K Sell
3,630
-147
-4% -$17.1K 0.04% 115
2021
Q3 		$427K Buy
3,777
+126
+3% +$14.4K 0.04% 110
2021
Q2 		$378K Sell
3,651
-65
-2% -$6.13K 0.04% 109
2021
Q1 		$337K Buy
3,716
+147
+4% +$12.4K 0.04% 114
2020
Q4 		$326K Buy
+3,569
New +$296K 0.04% 114

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Laird Norton Wetherby Trust Company's EW Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Edwards Lifesciences (EW) stake by 2.7% in Q2 2026, selling an estimated $51.7K and leaving 22,586 shares worth $2.04M. The position accounts for 0.04% of the portfolio, ranked #336.

Laird Norton Wetherby Trust Company first reported a position in EW in Q4 2020 and has held it in 9 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 22,586 shares of Edwards Lifesciences worth $2.04M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 617 Edwards Lifesciences shares in Q2 2026, an estimated $51.7K.
  • Edwards Lifesciences made up 0.04% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #336 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 9 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.